The Impact of Spondyloarthritis on Health-Related Quality of Life and Healthcare Resource Utilization in Saudi Arabia: A Narrative Review and Directions for Future Research

References

• Van der Horst Bruinsma IE, Nurmohamed MT. Management and evaluation of extra-articular manifestations in spondyloarthritis. Ther Adv Musculoskelet Dis. 2012;4(6):413–422. doi:10.1177/1759720X12458372
   PubMedGoogle Scholar
• Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73–84. doi:10.1016/S0140-6736(16)31591-4
   PubMed Web of Science ®Google Scholar
• Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63(5):1099–1112. doi:10.1016/0092-8674(90)90512-D
   PubMed Web of Science ®Google Scholar
• Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30(2):137–143. doi:10.1097/BOR.0000000000000475
   PubMed Web of Science ®Google Scholar
• Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res. 2016;68(9):1320–1331. doi:10.1002/acr.22831
   PubMed Web of Science ®Google Scholar
• Ramiro S, Van Tubergen A, Stolwijk C, et al. Reference intervals of spinal mobility measures in normal individuals: the mobility study. Ann Rheum Dis. 2015;74(6):1218–1224. doi:10.1136/annrheumdis-2013-204953
   PubMed Web of Science ®Google Scholar
• Erol K, Gok K, Cengiz G, Kilic G, Kilic E, Ozgocmen S. Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis. Acta Reumatol Port. 2018;43(1):32–39.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Landewé R, Van Der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009. doi:10.1136/ard.2009.108217
   Web of Science ®Google Scholar
• Siebert S, George Fragoulis IM. Spondyloarthritis: pathogenesis, clinical aspects and diagnosis EULAR on-line course on Rheumatic Diseases. EULAR on-Line Course Rheum Dis. 2017:A1037.
   Google Scholar
• Moll JMH, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, reiter’s disease, the intestinal arthropathies, and behcet’s syndrome. Med. 1974;53(5):56. doi:10.1097/00005792-197409000-00002
   Web of Science ®Google Scholar
• Rudwaleit M, Van Der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–783. doi:10.1136/ard.2009.108233
   PubMed Web of Science ®Google Scholar
• Mandl P, Navarro-Compán V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327–1339. doi:10.1136/annrheumdis-2014-206971
   PubMed Web of Science ®Google Scholar
• Du MS, Xiong XQ, Liu H, Qin X, Hu XF, Chen W. The evaluation of bone marrow edema in sacroiliac joint in patients with ankylosing spondylitis using magnetic resonance imaging Dixon sequence. BMC Musculoskelet Disord. 2021;22(1):919. doi:10.1186/s12891-021-04716-5
   PubMed Web of Science ®Google Scholar
• Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286.
   PubMed Web of Science ®Google Scholar
• MacHado P, Landewé R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70(1):47–53. doi:10.1136/ard.2010.138594
   PubMed Web of Science ®Google Scholar
• Hammoudeh M, Abdulaziz S, Alosaimi H, et al. Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: an expert consensus. J Int Med Res. 2016;44(2):216–230. doi:10.1177/0300060515611536
   PubMed Web of Science ®Google Scholar
• Wong PCH, Leung YY, Li EK, Tam LS. Measuring disease activity in psoriatic arthritis. Int J Rheumatol. 2012;2012. doi:10.1155/2012/839425
   PubMedGoogle Scholar
• Coates LC, Corp N, van der Windt DA, O’Sullivan D, Soriano ER, Kavanaugh A. GRAPPA Treatment Recommendations: 2021 Update. J Rheumatol. 2022;jrheum.211331. doi:10.3899/jrheum.211331
   Web of Science ®Google Scholar
• Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019;71(1):5–32. doi:10.1002/ART.40726
   PubMed Web of Science ®Google Scholar
• Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465–479. doi:10.1038/s41584-022-00798-0
   PubMed Web of Science ®Google Scholar
• Duba AS, Mathew SD. The Seronegative Spondyloarthropathies. Prim Care Clin off Pract. 2018;45(2):271–287. doi:10.1016/j.pop.2018.02.005
   PubMed Web of Science ®Google Scholar
• Singh JA, Strand V. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009;36(5):1012–1020. doi:10.3899/jrheum.081015
   PubMed Web of Science ®Google Scholar
• Ramonda R, Marchesoni A, Carletto A, et al. Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey. Arthritis Res Ther. 2016;18(1):1–7. doi:10.1186/s13075-016-0977-2
   PubMedGoogle Scholar
• Tayel MY, Soliman E, El Baz WF, El Labaan A, Hamaad Y, Ahmed MH. Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population. Rheumatol Int. 2012;32(9):2837–2842. doi:10.1007/s00296-011-2068-7
   PubMed Web of Science ®Google Scholar
• Hammoudeh M, Al Rayes H, Alawadhi A, Gado K, Shirazy K, Deodhar A. Clinical assessment and management of spondyloarthritides in the Middle East: a multinational investigation. Int J Rheumatol. 2015;2015. doi:10.1155/2015/178750
   Google Scholar
• Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: a hospital claims database analysis. Mod Rheumatol. 2020;31(2):431–441. doi:10.1080/14397595.2020.1775927
   PubMed Web of Science ®Google Scholar
• Claudepierre P, Van den Bosch F, Sarzi-Puttini P, Vastesaeger N, Govoni M, Kachroo S. Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort. Int J Rheum Dis. 2019;22(6):995–1001. doi:10.1111/1756-185X.13526
   PubMed Web of Science ®Google Scholar
• Emery P, Van Keep M, Beard S, et al. Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. Pharmacoeconomics. 2018;36(8):1015–1027. doi:10.1007/s40273-018-0675-9
   PubMed Web of Science ®Google Scholar
• General Authority of Statistics. Population In Saudi Arabia by Gender, Age, Nationality (Saudi / Non-Saudi) - Mid 2016 A.D | general Authority for Statistics.
   Google Scholar
• Rajapakse CNA. The spectrum of rheumatic diseases in Saudi Arabia. Rheumatology. 1987;26(1):22–23. doi:10.1093/rheumatology/26.1.22
   Web of Science ®Google Scholar
• Omair MA, AlDuraibi FK, Bedaiwi MK, et al. Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia. Clin Rheumatol. 2017;36(7):1537–1543. doi:10.1007/s10067-017-3655-0
   PubMed Web of Science ®Google Scholar
• Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(1):28–34. doi:10.1016/j.semarthrit.2018.01.003
   PubMed Web of Science ®Google Scholar
• Moghimi N, Davatchi F, Rahimi E, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran. Clin Rheumatol. 2015;34(3):535–543. doi:10.1007/s10067-013-2430-0
   PubMed Web of Science ®Google Scholar
• Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med. 2008;11(2):162–165.
   PubMed Web of Science ®Google Scholar
• Al-Awadhi AM, Olusi SO, Al-Saeid K, et al. Incidence of musculoskeletal pain in adult Kuwaitis using the validated Arabic version of the WHO-ILAR COPCORD core questionnaire. Ann Saudi Med. 2005;25(6):459–462. doi:10.5144/0256-4947.2005.459
   PubMed Web of Science ®Google Scholar
• Akkoc N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr Rheumatol Rep. 2008;10(5):371–378. doi:10.1007/s11926-008-0060-3
   PubMedGoogle Scholar
• Saleh J. The Prevalence and the Determinants of Musculoskeletal Diseases in Emiratis Attending Primary Health Care Clinics in Dubai. Oman Med J. 2016;31(2):117. doi:10.5001/OMJ.2016.23
   PubMedGoogle Scholar
• Elnady B, El Shaarawy NK, Dawoud NM, et al. Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years. Clin Rheumatol. 2019;38(6):1627–1635. doi:10.1007/s10067-019-04445-0
   PubMed Web of Science ®Google Scholar
• Zhang S, Li Y, Deng X, Huang F. Similarities and differences between spondyloarthritis in Asia and other parts of the world. Curr Opin Rheumatol. 2011;23(4):334–338. doi:10.1097/BOR.0b013e32834640a9
   PubMed Web of Science ®Google Scholar
• Claudepierre P, Gueguen A, Ladjouze A, et al. Predictive factors of severity of spondyloarthropathy in North Africa. Rheumatology. 1995;34(12):1139–1145. doi:10.1093/rheumatology/34.12.1139
   Web of Science ®Google Scholar
• Askari A, Al-Bdour MD, Saadeh A, Sawalha AH. Ankylosing spondylitis in north Jordan: descriptive and analytical study. Ann Rheum Dis. 2000;59(7):571–573. doi:10.1136/ard.59.7.571
   PubMed Web of Science ®Google Scholar
• Bedaiwi M, Al-Homood IA, El-Garf A, et al. Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East. Rheumatol Int. 2019;39(8):1321–1329. doi:10.1007/s00296-019-04319-3
   PubMed Web of Science ®Google Scholar
• Bedaiwi MK, Baeshen MO, Bin Zuair A, AlRasheed RF. The Delay of Diagnosis in Spondyloarthropathy Patients in a Tertiary Hospital in Saudi Arabia. Cureus. 2021;13(1). doi:10.7759/cureus.12629
   Web of Science ®Google Scholar
• Al-Arfaj A. Profile of ankylosing spondylitis in Saudi Arabia. Clin Rheumatol. 1996;15(3):287–289. doi:10.1007/BF02229709
   PubMed Web of Science ®Google Scholar
• Strand V, Singh JA. Patient Burden of Axial Spondyloarthritis. J Clin Rheumatol. 2017;23(7):383–391. doi:10.1097/RHU.0000000000000589
   PubMed Web of Science ®Google Scholar
• Nikiphorou E, Ramiro S, van der Heijde D, et al. Association of Comorbidities in Spondyloarthritis With Poor Function, Work Disability, and Quality of Life: results From the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis Care Res. 2018;70(8):1257–1262. doi:10.1002/acr.23468
   Web of Science ®Google Scholar
• Fallahi S, Jamshidi AR. Diagnostic delay in ankylosing spondylitis: related factors and prognostic outcomes. Arch Rheumatol. 2016;31(1):24–30. doi:10.5606/ArchRheumatol.2016.5562
   PubMed Web of Science ®Google Scholar
• Deodhar A, Mease PJ, Reveille JD, et al. Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain. Arthritis Rheumatol. 2016;68(7):1669–1676. doi:10.1002/art.39612
   PubMed Web of Science ®Google Scholar
• Sykes MP, Doll H, Sengupta R, Gaffney K. Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? Rheumatol. 2015;kev288. doi:10.1093/rheumatology/kev288
   Google Scholar
• Masson Behar V, Dougados M, Etcheto A, et al. Diagnostic delay in axial spondyloarthritis: a cross-sectional study of 432 patients. Jt Bone Spine. 2017;84(4):467–471. doi:10.1016/j.jbspin.2016.06.005
   PubMed Web of Science ®Google Scholar
• Redeker I, Callhoff J, Hoffmann F, et al. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Rheumatol. 2019;58(9):1634. doi:10.1093/rheumatology/kez090
   PubMed Web of Science ®Google Scholar
• Garrido-Cumbrera M, Poddubnyy D, Gossec L, et al. The European Map of Axial Spondyloarthritis: capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries. Curr Rheumatol Rep. 2019;21(5). doi:10.1007/s11926-019-0819-8
   PubMed Web of Science ®Google Scholar
• Karmacharya P, Wright K, Achenbach SJ, et al. Diagnostic Delay in Psoriatic Arthritis: a Population-based Study. J Rheumatol. 2021:jrheum.201199. doi:10.3899/jrheum.201199
   Google Scholar
• Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968. doi:10.1136/annrheumdis-2013-204428
   PubMed Web of Science ®Google Scholar
• Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028–2037. doi:10.1002/art.34347
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Datta S. Comprehensive Review of Epidemiology, Scope, and Impact of Spinal Pain. Pain Physician. 2009;4;12(4;7):E35–E70. doi:10.36076/ppj.2009/12/E35
   PubMed Web of Science ®Google Scholar
• Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis. 1973;32(4):354–363. doi:10.1136/ard.32.4.354
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361.
   PubMed Web of Science ®Google Scholar
• Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369–1374. doi:10.1136/ard.2010.145995
   PubMed Web of Science ®Google Scholar
• Wang R, Gabriel SE, Ward MM. Progression of Nonradiographic Axial Spondyloarthritis to Ankylosing Spondylitis: a Population-Based Cohort Study. Arthritis Rheumatol. 2016;68(6):1415–1421. doi:10.1002/art.39542
   PubMed Web of Science ®Google Scholar
• Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM. Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of spondyloarthritis international society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res. 2013;65(8):1299–1306. doi:10.1002/acr.21994
   Web of Science ®Google Scholar
• Congi L, Roussou E. Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria. Clin Exp Rheumatol. 2010;28(3):304–310.
   PubMed Web of Science ®Google Scholar
• Tillett W, Costa L, Jadon D, et al. The ClASsification for Psoriatic ARthritis (CASPAR) Criteria – a Retrospective Feasibility, Sensitivity, and Specificity Study: table 1. J Rheumatol. 2012;39(1):154–156. doi:10.3899/jrheum.110845
   PubMed Web of Science ®Google Scholar
• Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clin Rheumatol. 2019;38(3):625–634. doi:10.1007/s10067-018-4397-3
   PubMed Web of Science ®Google Scholar
• Magrey M, Yi E, Wolin D, et al. SAT0338 Delayed Diagnosis of Ankylosing Spondylitis: Results from a Survey of 1690 Us Physicians from 10 Specialties. Clin Aspects. 2019;78:567. doi:10.1136/annrheumdis-2019-eular.501
   Google Scholar
• Rudwaleit M, Landewe R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770–776. doi:10.1136/ard.2009.108217
   PubMed Web of Science ®Google Scholar
• Abdelrahman FI, Mortada M. AB0858 Impact of application of asas criteria for axial spondyloarthritis on the diagnostic delay in egyptian patients. In: Spondyloarthritis – Clinical Aspects (Other Than Treatment). BMJ Publishing Group Ltd and European League Against Rheumatism; 2018:1556.3–1557. doi:10.1136/annrheumdis-2018-eular.6965
   Google Scholar
• Yi E, Ahuja A, Rajput T, George AT, Park Y. Clinical, Economic, and Humanistic Burden Associated With Delayed Diagnosis of Axial Spondyloarthritis: a Systematic Review. Rheumatol Ther. 2020;7(1):65–87. doi:10.1007/s40744-020-00194-8
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Malaviya AN. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes - An Indian perspective. Clin Rheumatol. 2009. doi:10.1007/s10067-008-1049-z
   Web of Science ®Google Scholar
• Gunasekera W, Shaddick G, Jobling A, Smith A, Sengupta R. AB0735 Diagnostic Delay Worsens Mobility and Work Disability in Ankylosing Spondylitis. Ann Rheum Dis. 2014;73(Suppl 2):1046.2–1046. doi:10.1136/annrheumdis-2014-eular.4528
   Google Scholar
• Ibn Yacoub Y, Amine B, Laatiris A, Bensabbah R, Hajjaj-Hassouni N. Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis. Rheumatol Int. 2012;32(2):357–360. doi:10.1007/s00296-010-1635-7
   PubMed Web of Science ®Google Scholar
• Cakar E, Taskaynatan MA, Dincer U, Kiralp MZ, Durmus O, Ozgül A. Work disability in ankylosing spondylitis: differences among working and disabled patients. Clin Rheumatol. 2009;28(11):1309–1314. doi:10.1007/s10067-009-1249-1
   PubMed Web of Science ®Google Scholar
• Slobodin G, Reyhan I, Avshovich N, et al. Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol. 2011;30(8):1075–1080. doi:10.1007/s10067-011-1719-0
   PubMed Web of Science ®Google Scholar
• Seo MR, Baek HL, Yoon HH, et al. Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol. 2015;34(8):1397–1405. doi:10.1007/s10067-014-2768-y
   PubMed Web of Science ®Google Scholar
• Zhao J, Zheng W, Zhang C, Li J, Liu D, Xu W. Radiographic Hip involvement in ankylosing spondylitis: factors associated with severe Hip diseases. J Rheumatol. 2015;42(1):106–110. doi:10.3899/jrheum.140428
   PubMed Web of Science ®Google Scholar
• Russu E, Chislari L, Larisa R, Cazac V. AB0856 The impact of systemic inflammation and radiological changes on mobility in anchylosing spondylities. Int J Med. 2018:1556.1–1556. doi:10.1136/annrheumdis-2018-eular.3650
   Google Scholar
• Sitlinger A, Zafar SY. Health-Related Quality of Life: the Impact on Morbidity and Mortality. Surg Oncol Clin N Am. 2018;27(4):675–684. doi:10.1016/j.soc.2018.05.008
   PubMed Web of Science ®Google Scholar
• Karimi M, Brazier J. Health, Health-Related Quality of Life, and Quality of Life: what is the Difference? Pharmacoeconomics. 2016;34(7):645–649. doi:10.1007/s40273-016-0389-9
   PubMed Web of Science ®Google Scholar
• Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T. Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review. Expert Rev Pharmacoeconomics Outcomes Res. 2014;14(6):857–872. doi:10.1586/14737167.2014.957679
   PubMed Web of Science ®Google Scholar
• Boonen A, Sieper J, van der Heijde D, et al. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2015;44(5):556–562. doi:10.1016/j.semarthrit.2014.10.009
   PubMed Web of Science ®Google Scholar
• Martindale J, Goodacre L. The Journey to Diagnosis in AS/Axial SpA: the Impact of Delay. Musculoskeletal Care. 2014;12(4):221–231. doi:10.1002/msc.1080
   PubMedGoogle Scholar
• Fitzgerald G, Gallagher P, O’Sullivan C, et al. 112. Delayed diagnosis of axial spondyloarthropathy is associated with a higher prevalence of depression. Rheumatology. 2017;56. doi:10.1093/rheumatology/kex062.112
   Web of Science ®Google Scholar
• G SE, M BJ, B RR. Burden of delay to diagnosis of ankylosing spondylitis. Arthritis Rheum. 2011;63:S512.
   Google Scholar
• Sieper J, Lenaerts J, Wollenhaupt J, et al. Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis. 2014;73(1):101–107. doi:10.1136/annrheumdis-2012-203201
   PubMed Web of Science ®Google Scholar
• Robinson PC, Sengupta R, Siebert S. Non-Radiographic Axial Spondyloarthritis (nr-axSpA): advances in Classification, Imaging and Therapy. Rheumatol Ther. 2019;6(2):165–177. doi:10.1007/s40744-019-0146-6
   PubMed Web of Science ®Google Scholar
• Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19 LP–34 . doi:10.1136/ard-2022-223296
   Web of Science ®Google Scholar
• Gladman DD, Mease PJ, Strand V, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol. 2007;34:1167–1170.
   PubMed Web of Science ®Google Scholar
• Zhu TY, Tam LS, Lee VWY, et al. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong. Rheumatology. 2008;47(9):1422–1425. doi:10.1093/rheumatology/ken287
   PubMed Web of Science ®Google Scholar
• López-Medina C, Garrido-Castro JL, Castro-Jiménez J, et al. Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. Clin Rheumatol. 2018;37(6):1581–1588. doi:10.1007/s10067-018-4112-4
   PubMed Web of Science ®Google Scholar
• Smolen JS, Schöls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77(1):3–17. doi:10.1136/annrheumdis-2017-211734
   PubMed Web of Science ®Google Scholar
• Chiowchanwisawakit P, Srinonprasert V, Thaweeratthakul P, Katchamart W. Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: a cross-sectional study. Int J Rheum Dis. 2019;22(4):700–707. doi:10.1111/1756-185X.13473
   PubMed Web of Science ®Google Scholar
• Mody GM. Rheumatology in Africa-challenges and opportunities. Arthritis Res Ther. 2017;19(1). doi:10.1186/s13075-017-1259-3
   PubMedGoogle Scholar
• El Zorkany B, AlWahshi HA, Hammoudeh M, et al. Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? Clin Rheumatol. 2013;32(2):151–159. doi:10.1007/s10067-012-2153-7
   PubMed Web of Science ®Google Scholar
• Watad A, Al-Saleh J, Lidar M, Amital H, Shoenfeld Y. Rheumatology in the Middle East in 2017: clinical challenges and research. Arthritis Res Ther. 2017;19(1). doi:10.1186/s13075-017-1359-0
   PubMedGoogle Scholar
• Al Marzooqi AM, Al Saleh J. AB0983 What Is The Fastest Route for Patients with Inflammatory Arthritis To Early Arthritis Clinic. Ann Rheum Dis. 2016;75(Suppl 2):1237.2–1237. doi:10.1136/annrheumdis-2016-eular.2564
   Google Scholar
• Boonen A, Mau W. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27(4):S112.
   PubMed Web of Science ®Google Scholar
• Greenberg JD, Palmer JB, Li Y, Herrera V, Tsang Y, Liao M. Healthcare resource use and direct costs in patients with ankylosing spondylitis and psoriatic arthritis in a large US cohort. J Rheumatol. 2016;43(1):88–96. doi:10.3899/jrheum.150540
   PubMed Web of Science ®Google Scholar
• Sullivan C, Fitzgerald OM. Time to diagnosis of Ankylosing Spondylitis in an Irish cohort and the effect on work disability. Arthritis Rheum. 2010;62:1533–1538. doi:10.1002/art.27379
   PubMedGoogle Scholar
• Abdul-Sattar A, Abou El Magd S. Prevalence and associated risk factors for work disability in Egyptian patients with ankylosing spondylitis from one center. Int J Rheum Dis. 2017;20(12):2028–2034. doi:10.1111/1756-185X.12306
   PubMed Web of Science ®Google Scholar
• Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M. Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy. Clin Outcomes Res. 2018;Volume 10:45–51. doi:10.2147/CEOR.S144209
   Web of Science ®Google Scholar
• Sullivan C, Quinn K, Harney S, Ryan JG. The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay. Ir J Med Sci. 2014;183(4):579–584. doi:10.1007/s11845-013-1054-3
   PubMed Web of Science ®Google Scholar
• Merola JF, Dennis N, Chakravarty SD, et al. Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA–a retrospective study of claims data from 2009 to 2020. Clin Rheumatol. 2021;40(10):4061–4070. doi:10.1007/s10067-021-05713-8
   PubMed Web of Science ®Google Scholar
• Codreanu C, Mogosanu C, Joita M, Purcaru O. Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania. Value Heal. 2014;17(7):A379. doi:10.1016/j.jval.2014.08.2608
   PubMed Web of Science ®Google Scholar
• Ferrando R, Echave M, Espinoza Cámac N, Maratia S, Casado MÁ. PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain. Value Heal. 2020;23:S596. doi:10.1016/j.jval.2020.08.1152
   Web of Science ®Google Scholar
• Merola JF, Landewé R, McInnes IB, et al. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, Phase 3 trial (BE COMPLETE). Lancet. 2023;401(10370):38–48. doi:10.1016/S0140-6736(22)02303-0
   PubMed Web of Science ®Google Scholar
• McInnes IB, Asahina A, Coates LC, et al. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet. 2023;401(10370):25–37. doi:10.1016/S0140-6736(22)02302-9
   PubMed Web of Science ®Google Scholar
• El Zorkany B, Ali YM, Namas R, et al. The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: from diagnosis to management. Int J Rheum Dis. 2020;23(11):1574–1580. doi:10.1111/1756-185X.13961
   PubMed Web of Science ®Google Scholar
• Alam F, Lutf AQ, Abdulla N, Elsayed EHS, Hammoudeh M. Characteristics of Ankylosing Spondylitis patients living in Qatar. Egypt Rheumatol. 2017;39(2):103–108. doi:10.1016/j.ejr.2016.09.001
   Google Scholar